Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease

Affiliations

• ¹ Inflammatory Bowel Disease Clinic, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
• ² Alberta Precision Laboratories, Public Health Laboratory, Calgary, Alberta, Canada.
• ³ Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
• ⁴ Division of Infectious Diseases, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
• ⁵ Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
• ⁶ Department of Clinical Neuroscience, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
• ⁷ University of Manitoba IBD Clinical and Research Centre and Department of Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
• ⁸ Department of Microbiology, Immunology and Infectious Disease, University of Calgary, Calgary, Alberta, Canada.
• ⁹ Divisions of Rheumatology and Clinical Epidemiology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
• ¹⁰ ICES, Toronto, Ontario, Canada.
• ¹¹ SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada.
• ¹² Department of Paediatrics and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
• ¹³ Inflammatory Bowel Disease Clinic, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada ggkaplan@ucalgary.ca.